Suzuki T, Yoshida E, Yoshii T, Koike Y, Misawa M, Yanaura S
Department of Applied Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.
Yakubutsu Seishin Kodo. 1988 Jun;8(2):337-43.
The effects of noscapine and chlorpheniramine on physical dependence liability and antitussive activity of dihydrocodeine, a narcotic antitussive, were studied. For developing physical dependence, male Sprague-Dawley rats were treated with dihydrocodeine (DC), noscapine (N), and chlorpheniramine (CP) singly or simultaneously admixed with food (drug-admixed food method (DAF): DC: 0.125, N: 0.25, CP: 0.05 mg/g of food, for 7 days) or were intermittently medicated for 3 days at one-hour intervals through an implanted intravenous cannula (infusion method: DC: 0.5-2, N: 1-4, CP: 0.2-0.8 mg/kg x 24 times/day). Subsequently, rats were treated with naloxone (0.5 mg/kg, sc) and checked for withdrawal signs during 3 hours. Naloxone-precipitated body weight loss of DC was suppressed by simultaneous administration of N or CP. In combined group of DC, N, and CP, withdrawal signs, such as body weight loss, body shakes, and diarrhea, were more remarkably suppressed. Papaverine, the same kind of spasmolytic as N, was tested by the same schedule of DAF. Papaverine did not suppress the naloxone-precipitated withdrawal signs of DC. These results suggest that suppressive effect of N is not due to its spasmolytic action. On the other hand, the cough reflex was induced by electric stimulation in guinea pigs and the fifty percent of antitussive dose (AtD50) was estimated in order to evaluate the influence of N and CP on antitussive effect of DC. N and CP did not change the antitussive effect of DC. These results may suggest that N and CP suppress the development of physical dependence of DC without diminishing the pharmacological effects of DC.
研究了那可丁和氯苯那敏对麻醉性镇咳药二氢可待因身体依赖性倾向及镇咳活性的影响。为建立身体依赖性,将雄性Sprague-Dawley大鼠单独或同时与食物混合给予二氢可待因(DC)、那可丁(N)和氯苯那敏(CP)(药物混食法(DAF):DC:0.125、N:0.25、CP:0.05mg/g食物,持续7天),或通过植入的静脉插管以1小时间隔间歇性给药3天(输注法:DC:0.5 - 2、N:1 - 4、CP:0.2 - 0.8mg/kg×每天24次)。随后,大鼠接受纳洛酮(0.5mg/kg,皮下注射)治疗,并在3小时内检查戒断症状。同时给予N或CP可抑制纳洛酮引起的DC体重减轻。在DC、N和CP联合组中,体重减轻、身体颤抖和腹泻等戒断症状得到更显著抑制。与N同类的解痉药罂粟碱按相同的DAF方案进行测试。罂粟碱未抑制纳洛酮引起的DC戒断症状。这些结果表明,N的抑制作用并非因其解痉作用。另一方面,通过电刺激在豚鼠中诱发咳嗽反射,并评估半数镇咳剂量(AtD50),以评价N和CP对DC镇咳作用的影响。N和CP未改变DC的镇咳作用。这些结果可能表明,N和CP可抑制DC身体依赖性的发展,而不减弱DC的药理作用。